| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.997 | 0 | 0.997 | Cathepsin D inhibitor | |||
| 0.924 | 0.003 | 0.924 | Aldehyde oxidase inhibitor | 0.586 0.021 DBMET00328 0.287 0.07 DBMET00585 | ||
| 0.9 | 0.002 | 0.9 | Alcohol oxidase inhibitor | 0.853 0.002 DBMET00328 0.218 0.006 DBMET00585 | ||
| 0.827 | 0.002 | 0.88 | Alpha-N-acetylglucosaminidase inhibitor | 0.816 0.002 DBMET00328 0.88 0.001 DBMET00585 | DBMET00585 | |
| 0.716 | 0.004 | 0.716 | Superoxide dismutase inhibitor | 0.571 0.008 DBMET00328 0.193 0.125 DBMET00585 | ||
| 0.664 | 0.009 | 0.664 | 5 Hydroxytryptamine release stimulant | 0.477 0.031 DBMET00328 0.612 0.013 DBMET00585 | ||
| 0.64 | 0.007 | 0.64 | 5 Hydroxytryptamine release inhibitor | 0.441 0.056 DBMET00328 0.595 0.012 DBMET00585 | ||
| 0.607 | 0.007 | 0.607 | GABA C receptor rho-3 antagonist | 0.567 0.012 DBMET00328 | ||
| 0.588 | 0.005 | 0.588 | Peroxidase inhibitor | 0.405 0.02 DBMET00328 | ||
| 0.599 | 0.019 | 0.827 | Cholesterol antagonist | 0.318 0.08 DBMET00328 0.827 0.004 DBMET00585 | DBMET00585 | |
| 0.577 | 0.04 | 0.735 | Caspase 9 stimulant | 0.446 0.085 DBMET00328 0.735 0.02 DBMET00585 | DBMET00585 | |
| 0.539 | 0.003 | 0.539 | Succinate dehydrogenase inhibitor | 0.445 0.004 DBMET00328 0.224 0.033 DBMET00585 | ||
| 0.549 | 0.016 | 0.74 | Histamine release inhibitor | 0.359 0.096 DBMET00328 0.74 0.004 DBMET00585 | DBMET00585 | |
| 0.505 | 0.008 | 0.642 | Anesthetic general | 0.247 0.051 DBMET00328 0.642 0.004 DBMET00585 | DBMET00585 | |
| 0.489 | 0.004 | 0.601 | Aldehyde dehydrogenase inhibitor | 0.601 0.004 DBMET00328 0.275 0.014 DBMET00585 | DBMET00328 | |
| 0.504 | 0.026 | 0.504 | Calcium channel L-type activator | |||
| 0.473 | 0.004 | 0.473 | Tyrosine 3 hydroxylase inhibitor | 0.358 0.014 DBMET00328 | ||
| 0.495 | 0.036 | 0.533 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.533 0.021 DBMET00328 | DBMET00328 | |
| 0.455 | 0.003 | 0.593 | Triose-phosphate isomerase inhibitor | 0.423 0.003 DBMET00328 0.593 0.002 DBMET00585 | DBMET00585 | |
| 0.455 | 0.004 | 0.548 | UDP-glucose 4-epimerase inhibitor | 0.432 0.004 DBMET00328 0.548 0.002 DBMET00585 | DBMET00585 | |
| 0.457 | 0.007 | 0.457 | Phospholipase C inhibitor | 0.184 0.057 DBMET00328 0.247 0.025 DBMET00585 | ||
| 0.448 | 0.004 | 0.448 | GABA C receptor agonist | 0.365 0.006 DBMET00328 0.112 0.055 DBMET00585 | ||
| 0.463 | 0.037 | 0.626 | Vasodilator, peripheral | 0.221 0.153 DBMET00328 0.626 0.013 DBMET00585 | DBMET00585 | |
| 0.419 | 0.018 | 0.419 | Calcium channel activator | 0.344 0.054 DBMET00328 0.285 0.107 DBMET00585 | ||
| 0.398 | 0.004 | 0.398 | Ferrochelatase inhibitor | 0.367 0.004 DBMET00328 | ||
| 0.416 | 0.03 | 0.752 | Vasodilator, coronary | 0.27 0.114 DBMET00328 0.752 0.004 DBMET00585 | DBMET00585 | |
| 0.393 | 0.015 | 0.393 | 5 Hydroxytryptamine uptake stimulant | 0.388 0.016 DBMET00328 | ||
| 0.387 | 0.019 | 0.387 | RNA-directed DNA polymerase inhibitor | 0.277 0.037 DBMET00328 0.321 0.028 DBMET00585 | ||
| 0.37 | 0.004 | 0.37 | Catalase inhibitor | 0.244 0.009 DBMET00328 0.072 0.053 DBMET00585 | ||
| 0.386 | 0.021 | 0.663 | Interleukin agonist | 0.246 0.081 DBMET00328 0.663 0.004 DBMET00585 | DBMET00585 | |
| 0.379 | 0.025 | 0.522 | DNA synthesis inhibitor | 0.359 0.028 DBMET00328 0.522 0.012 DBMET00585 | DBMET00585 | |
| 0.358 | 0.005 | 0.59 | NADH dehydrogenase inhibitor | 0.192 0.011 DBMET00328 0.59 0.002 DBMET00585 | DBMET00585 | |
| 0.347 | 0.004 | 0.347 | Phenylalanine 4-hydroxylase inhibitor | 0.114 0.02 DBMET00328 0.084 0.035 DBMET00585 | ||
| 0.353 | 0.012 | 0.458 | Peptidyltransferase inhibitor | 0.458 0.004 DBMET00585 | DBMET00585 | |
| 0.344 | 0.004 | 0.344 | Porphobilinogen synthase inhibitor | 0.308 0.005 DBMET00328 | ||
| 0.366 | 0.034 | 0.762 | Hypoglycemic | 0.762 0.004 DBMET00585 | DBMET00585 | |
| 0.344 | 0.013 | 0.721 | Amylase inhibitor | 0.285 0.02 DBMET00328 0.721 0.003 DBMET00585 | DBMET00585 | |
| 0.361 | 0.033 | 0.361 | Sodium/bile acid cotransporter inhibitor | 0.216 0.166 DBMET00585 | ||
| 0.331 | 0.004 | 0.331 | Carbamoyl phosphate synthetase inhibitor | 0.162 0.01 DBMET00328 0.152 0.011 DBMET00585 | ||
| 0.329 | 0.004 | 0.329 | Creatine kinase inhibitor | 0.186 0.013 DBMET00328 0.104 0.055 DBMET00585 | ||
| 0.326 | 0.005 | 0.356 | Adenylate kinase inhibitor | 0.356 0.004 DBMET00328 0.274 0.008 DBMET00585 | DBMET00328 | |
| 0.327 | 0.007 | 0.344 | Nitric-oxide synthase stimulant | 0.263 0.025 DBMET00328 0.344 0.005 DBMET00585 | DBMET00585 | |
| 0.323 | 0.005 | 0.357 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.211 0.014 DBMET00328 0.357 0.004 DBMET00585 | DBMET00585 | |
| 0.321 | 0.004 | 0.321 | GABA C receptor antagonist | 0.212 0.011 DBMET00328 | ||
| 0.356 | 0.043 | 0.613 | Interleukin 2 agonist | 0.613 0.003 DBMET00585 | DBMET00585 | |
| 0.306 | 0.005 | 0.306 | GABA C receptor rho-2 antagonist | 0.237 0.014 DBMET00328 | ||
| 0.317 | 0.019 | 0.317 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.22 0.058 DBMET00328 0.284 0.029 DBMET00585 | ||
| 0.328 | 0.032 | 0.455 | Cyclic AMP phosphodiesterase inhibitor | 0.159 0.138 DBMET00328 0.455 0.01 DBMET00585 | DBMET00585 | |
| 0.314 | 0.024 | 0.314 | Gastrin inhibitor | 0.239 0.092 DBMET00328 0.26 0.068 DBMET00585 | ||
| 0.294 | 0.005 | 0.436 | Phosphofructokinase-1 inhibitor | 0.273 0.006 DBMET00328 0.436 0.003 DBMET00585 | DBMET00585 | |
| 0.352 | 0.064 | 0.75 | Antithrombotic | 0.301 0.087 DBMET00328 0.75 0.006 DBMET00585 | DBMET00585 | |
| 0.29 | 0.004 | 0.29 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.235 0.005 DBMET00328 0.286 0.004 DBMET00585 | ||
| 0.318 | 0.043 | 0.879 | Angiogenesis stimulant | 0.879 0.003 DBMET00585 | DBMET00585 | |
| 0.357 | 0.083 | 0.614 | Immunosuppressant | 0.614 0.011 DBMET00585 | DBMET00585 | |
| 0.291 | 0.02 | 0.291 | Neurotrophic factor enhancer | 0.216 0.062 DBMET00328 0.257 0.034 DBMET00585 | ||
| 0.273 | 0.008 | 0.273 | Histidine decarboxylase inhibitor | 0.156 0.019 DBMET00328 0.082 0.041 DBMET00585 | ||
| 0.271 | 0.008 | 0.321 | Mannose-6-phosphate isomerase inhibitor | 0.277 0.008 DBMET00328 0.321 0.005 DBMET00585 | DBMET00585 | |
| 0.325 | 0.072 | 0.606 | Immunostimulant | 0.25 0.096 DBMET00328 0.606 0.016 DBMET00585 | DBMET00585 | |
| 0.306 | 0.055 | 0.306 | Insulysin inhibitor | 0.265 0.083 DBMET00328 | ||
| 0.255 | 0.004 | 0.255 | GABA C receptor rho-1 antagonist | 0.184 0.011 DBMET00328 | ||
| 0.252 | 0.007 | 0.252 | Glutamate dehydrogenase inhibitor | 0.17 0.013 DBMET00328 0.175 0.012 DBMET00585 | ||
| 0.31 | 0.066 | 0.502 | Spasmolytic | 0.502 0.023 DBMET00585 | DBMET00585 | |
| 0.247 | 0.006 | 0.247 | Arachidonic acid antagonist | 0.212 0.023 DBMET00328 0.203 0.031 DBMET00585 | ||
| 0.244 | 0.003 | 0.244 | Acyl-CoA dehydrogenase inhibitor | 0.172 0.007 DBMET00328 0.183 0.006 DBMET00585 | ||
| 0.252 | 0.015 | 0.263 | 5 Hydroxytryptamine 3E antagonist | 0.263 0.011 DBMET00328 | DBMET00328 | |
| 0.24 | 0.005 | 0.24 | Keratolytic | 0.087 0.041 DBMET00328 0.07 0.064 DBMET00585 | ||
| 0.237 | 0.004 | 0.237 | Biliverdin reductase inhibitor | 0.162 0.008 DBMET00328 0.159 0.009 DBMET00585 | ||
| 0.313 | 0.088 | 0.722 | Transcription factor NF kappa B inhibitor | 0.29 0.1 DBMET00328 0.722 0.018 DBMET00585 | DBMET00585 | |
| 0.256 | 0.031 | 0.256 | Insulin sensitizer | 0.154 0.128 DBMET00328 0.246 0.037 DBMET00585 | ||
| 0.23 | 0.005 | 0.23 | Adenylate cyclase stimulant | 0.177 0.029 DBMET00328 0.195 0.016 DBMET00585 | ||
| 0.238 | 0.013 | 0.238 | Carbonic anhydrase XV inhibitor | 0.114 0.052 DBMET00328 | ||
| 0.229 | 0.005 | 0.244 | Glutamate decarboxylase inhibitor | 0.244 0.005 DBMET00328 0.067 0.059 DBMET00585 | DBMET00328 | |
| 0.235 | 0.015 | 0.235 | Aminopeptidase B inhibitor | 0.212 0.019 DBMET00328 | ||
| 0.227 | 0.009 | 0.237 | Mucolytic | 0.134 0.043 DBMET00328 0.237 0.008 DBMET00585 | DBMET00585 | |
| 0.245 | 0.029 | 0.461 | Interferon gamma antagonist | 0.173 0.055 DBMET00328 0.461 0.008 DBMET00585 | DBMET00585 | |
| 0.235 | 0.02 | 0.235 | Cholesterol synthesis inhibitor | 0.186 0.03 DBMET00328 0.195 0.028 DBMET00585 | ||
| 0.243 | 0.028 | 0.294 | Protein kinase stimulant | 0.127 0.086 DBMET00328 0.294 0.018 DBMET00585 | DBMET00585 | |
| 0.216 | 0.003 | 0.236 | Ca2+-transporting ATPase inhibitor | 0.183 0.006 DBMET00328 0.236 0.002 DBMET00585 | DBMET00585 | |
| 0.231 | 0.018 | 0.231 | Cystathionine beta-synthase inhibitor | 0.161 0.036 DBMET00328 0.174 0.031 DBMET00585 | ||
| 0.22 | 0.01 | 0.359 | Alcohol dehydrogenase inhibitor | 0.359 0.004 DBMET00328 0.189 0.014 DBMET00585 | DBMET00328 | |
| 0.262 | 0.054 | 0.262 | Psychostimulant | 0.169 0.101 DBMET00328 0.222 0.069 DBMET00585 | ||
| 0.217 | 0.01 | 0.33 | Photosensitizer | 0.154 0.029 DBMET00328 0.33 0.004 DBMET00585 | DBMET00585 | |
| 0.227 | 0.021 | 0.375 | Cell wall synthesis inhibitor | 0.148 0.068 DBMET00328 0.375 0.007 DBMET00585 | DBMET00585 | |
| 0.226 | 0.021 | 0.325 | ATPase inhibitor | 0.209 0.031 DBMET00328 0.325 0.005 DBMET00585 | DBMET00585 | |
| 0.221 | 0.016 | 0.221 | Toll-Like receptor 2 antagonist | 0.158 0.047 DBMET00328 0.123 0.074 DBMET00585 | ||
| 0.221 | 0.017 | 0.49 | Expectorant | 0.105 0.063 DBMET00328 0.49 0.004 DBMET00585 | DBMET00585 | |
| 0.211 | 0.008 | 0.211 | Sphingosine 1-phosphate receptor 5 antagonist | 0.15 0.061 DBMET00328 | ||
| 0.232 | 0.035 | 0.232 | Histone acetyltransferase inhibitor | |||
| 0.25 | 0.054 | 0.25 | MAP kinase kinase 2 inhibitor | |||
| 0.225 | 0.03 | 0.225 | Bone formation stimulant | 0.139 0.068 DBMET00585 | ||
| 0.198 | 0.008 | 0.278 | Argininosuccinate synthase inhibitor | 0.278 0.004 DBMET00328 0.137 0.013 DBMET00585 | DBMET00328 | |
| 0.198 | 0.008 | 0.198 | Sphingosine 1-phosphate receptor 2 antagonist | 0.138 0.059 DBMET00328 | ||
| 0.218 | 0.029 | 0.52 | Monophenol monooxygenase inhibitor | 0.52 0.007 DBMET00585 | DBMET00585 | |
| 0.192 | 0.003 | 0.192 | Aconitate hydratase inhibitor | 0.106 0.007 DBMET00328 0.056 0.03 DBMET00585 | ||
| 0.199 | 0.016 | 0.199 | Carbonic anhydrase III inhibitor | 0.096 0.067 DBMET00328 0.147 0.029 DBMET00585 | ||
| 0.191 | 0.008 | 0.191 | Aminopeptidase I inhibitor | 0.125 0.018 DBMET00328 0.067 0.058 DBMET00585 | ||
| 0.19 | 0.008 | 0.19 | DOPA decarboxylase inhibitor | 0.162 0.016 DBMET00328 | ||
| 0.211 | 0.029 | 0.301 | Hexokinase inhibitor | 0.2 0.035 DBMET00328 0.301 0.011 DBMET00585 | DBMET00585 | |
| 0.185 | 0.004 | 0.185 | Glycine receptor agonist | 0.117 0.014 DBMET00328 0.169 0.005 DBMET00585 | ||
| 0.187 | 0.007 | 0.187 | Ornithine carbamoyltransferase inhibitor | 0.17 0.008 DBMET00328 0.088 0.019 DBMET00585 | ||
| 0.296 | 0.116 | 0.406 | Calpain 2 inhibitor | 0.406 0.058 DBMET00328 | DBMET00328 | |
| 0.19 | 0.011 | 0.19 | Sphingosine 1-phosphate receptor 4 antagonist | 0.131 0.055 DBMET00328 | ||
| 0.242 | 0.064 | 0.242 | Neuropeptide Y2 antagonist | 0.193 0.133 DBMET00328 | ||
| 0.219 | 0.042 | 0.287 | 3C-like protease (Human coronavirus) inhibitor | 0.287 0.014 DBMET00328 | DBMET00328 | |
| 0.207 | 0.03 | 0.207 | Anesthetic local | 0.129 0.061 DBMET00328 | ||
| 0.204 | 0.029 | 0.204 | MAP kinase kinase 5 inhibitor | |||
| 0.187 | 0.012 | 0.187 | Sphingomyelinase inhibitor | 0.102 0.058 DBMET00328 0.164 0.019 DBMET00585 | ||
| 0.183 | 0.01 | 0.183 | Electrolyte absorption antagonist | 0.16 0.016 DBMET00328 | ||
| 0.242 | 0.071 | 0.455 | Hypolipemic | 0.455 0.017 DBMET00585 | DBMET00585 | |
| 0.175 | 0.004 | 0.175 | Granulocyte macrophage colony stimulating factor agonist | 0.144 0.006 DBMET00328 | ||
| 0.192 | 0.022 | 0.251 | Microtubule formation inhibitor | 0.167 0.03 DBMET00328 0.251 0.009 DBMET00585 | DBMET00585 | |
| 0.192 | 0.022 | 0.362 | Cyclooxygenase 3 inhibitor | 0.137 0.06 DBMET00328 0.362 0.004 DBMET00585 | DBMET00585 | |
| 0.174 | 0.004 | 0.174 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.068 0.023 DBMET00328 | ||
| 0.203 | 0.034 | 0.486 | Insulin secretagoues | 0.486 0.005 DBMET00585 | DBMET00585 | |
| 0.184 | 0.015 | 0.184 | HIV-1 integrase (Overall Integration) inhibitor | 0.103 0.052 DBMET00328 | ||
| 0.199 | 0.035 | 0.199 | Neurotensin receptor agonist | 0.162 0.075 DBMET00328 | ||
| 0.208 | 0.044 | 0.208 | Cytidine deaminase inhibitor | 0.114 0.107 DBMET00328 | ||
| 0.238 | 0.077 | 0.562 | Vasodilator | 0.562 0.008 DBMET00585 | DBMET00585 | |
| 0.184 | 0.024 | 0.184 | MAP3K9 inhibitor | |||
| 0.174 | 0.014 | 0.182 | Prolactin inhibitor | 0.182 0.012 DBMET00328 | DBMET00328 | |
| 0.175 | 0.015 | 0.175 | Heat shock protein 70 antagonist | 0.145 0.059 DBMET00328 0.172 0.016 DBMET00585 | ||
| 0.2 | 0.041 | 0.293 | Melanin inhibitor | 0.21 0.037 DBMET00328 0.293 0.023 DBMET00585 | DBMET00585 | |
| 0.22 | 0.06 | 0.322 | DNA methyltransferase I inhibitor | 0.322 0.019 DBMET00585 | DBMET00585 | |
| 0.163 | 0.003 | 0.163 | Glutamate (mGluR6) antagonist | 0.1 0.01 DBMET00328 0.091 0.015 DBMET00585 | ||
| 0.166 | 0.008 | 0.253 | Interferon agonist | 0.104 0.026 DBMET00328 0.253 0.004 DBMET00585 | DBMET00585 | |
| 0.209 | 0.051 | 0.209 | Lipocortins synthesis antagonist | 0.174 0.077 DBMET00585 | ||
| 0.16 | 0.002 | 0.21 | Glucose-6-phosphate isomerase inhibitor | 0.144 0.003 DBMET00328 0.21 0.001 DBMET00585 | DBMET00585 | |
| 0.163 | 0.006 | 0.163 | Sphingosine 1-phosphate receptor 4 agonist | 0.075 0.04 DBMET00328 | ||
| 0.176 | 0.02 | 0.188 | Vanilloid 1 agonist | 0.131 0.065 DBMET00328 0.188 0.015 DBMET00585 | DBMET00585 | |
| 0.215 | 0.06 | 0.469 | Non-steroidal antiinflammatory agent | 0.198 0.073 DBMET00328 0.469 0.008 DBMET00585 | DBMET00585 | |
| 0.162 | 0.008 | 0.216 | Glutamate release inhibitor | 0.12 0.022 DBMET00328 0.216 0.004 DBMET00585 | DBMET00585 | |
| 0.199 | 0.044 | 0.404 | Diuretic | 0.404 0.013 DBMET00585 | DBMET00585 | |
| 0.195 | 0.045 | 0.201 | Phospholipase A2 inhibitor | 0.139 0.087 DBMET00328 0.201 0.042 DBMET00585 | DBMET00585 | |
| 0.162 | 0.013 | 0.162 | MAP kinase kinase 1 inhibitor | |||
| 0.178 | 0.031 | 0.178 | Adenylate cyclase inhibitor | 0.144 0.049 DBMET00585 | ||
| 0.165 | 0.018 | 0.165 | Carbonic anhydrase VI inhibitor | 0.154 0.02 DBMET00585 | ||
| 0.181 | 0.035 | 0.184 | CF transmembrane conductance regulator agonist | 0.177 0.039 DBMET00328 0.184 0.033 DBMET00585 | DBMET00585 | |
| 0.15 | 0.004 | 0.15 | Estrogen-related receptor beta agonist | 0.106 0.018 DBMET00328 | ||
| 0.154 | 0.01 | 0.154 | Ornithine decarboxylase inhibitor | 0.13 0.019 DBMET00328 0.115 0.03 DBMET00585 | ||
| 0.156 | 0.015 | 0.156 | Anabolic | 0.144 0.021 DBMET00328 0.115 0.044 DBMET00585 | ||
| 0.144 | 0.004 | 0.35 | Alpha-mannosidase inhibitor | 0.11 0.005 DBMET00328 0.35 0.002 DBMET00585 | DBMET00585 | |
| 0.174 | 0.035 | 0.399 | Alkylator | 0.137 0.054 DBMET00328 0.399 0.008 DBMET00585 | DBMET00585 | |
| 0.211 | 0.072 | 0.423 | DNA methylase inhibitor | 0.423 0.009 DBMET00585 | DBMET00585 | |
| 0.172 | 0.034 | 0.257 | Interleukin 4 antagonist | 0.257 0.012 DBMET00585 | DBMET00585 | |
| 0.283 | 0.148 | 0.662 | Antibacterial | 0.263 0.165 DBMET00328 0.662 0.012 DBMET00585 | DBMET00585 | |
| 0.151 | 0.016 | 0.185 | Acetylcholine release stimulant | 0.12 0.048 DBMET00328 0.185 0.005 DBMET00585 | DBMET00585 | |
| 0.147 | 0.012 | 0.147 | Lanosterol 14 alpha demethylase inhibitor | 0.115 0.035 DBMET00328 | ||
| 0.155 | 0.021 | 0.155 | Calcium antagonist | 0.084 0.06 DBMET00328 | ||
| 0.154 | 0.021 | 0.159 | Carbonic anhydrase XIII inhibitor | 0.119 0.03 DBMET00328 0.159 0.02 DBMET00585 | DBMET00585 | |
| 0.22 | 0.089 | 0.22 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.154 | 0.024 | 0.154 | Sphingosine 1-phosphate receptor 2 agonist | |||
| 0.225 | 0.096 | 0.381 | DNA damaging | 0.381 0.033 DBMET00585 | DBMET00585 | |
| 0.162 | 0.034 | 0.162 | Pregnane X receptor agonist | 0.146 0.061 DBMET00328 | ||
| 0.132 | 0.004 | 0.338 | Mannosidase inhibitor | 0.096 0.006 DBMET00328 0.338 0.002 DBMET00585 | DBMET00585 | |
| 0.22 | 0.094 | 0.279 | Calpain inhibitor | 0.279 0.042 DBMET00328 | DBMET00328 | |
| 0.13 | 0.005 | 0.13 | GABA B receptor agonist | 0.087 0.03 DBMET00328 | ||
| 0.133 | 0.009 | 0.197 | Neuraminidase (influenza) inhibitor | 0.197 0.005 DBMET00585 | DBMET00585 | |
| 0.239 | 0.115 | 0.239 | 12-Lipoxygenase inhibitor | |||
| 0.162 | 0.038 | 0.223 | Cathepsin H inhibitor | 0.223 0.017 DBMET00328 | DBMET00328 | |
| 0.137 | 0.015 | 0.137 | Interleukin 5 antagonist | 0.086 0.061 DBMET00328 0.085 0.063 DBMET00585 | ||
| 0.127 | 0.006 | 0.181 | Interferon inducer | 0.064 0.045 DBMET00328 0.181 0.004 DBMET00585 | DBMET00585 | |
| 0.132 | 0.012 | 0.147 | GABA aminotransferase inhibitor | 0.102 0.025 DBMET00328 0.147 0.008 DBMET00585 | DBMET00585 | |
| 0.13 | 0.011 | 0.13 | NMDA receptor agonist | 0.062 0.044 DBMET00328 | ||
| 0.135 | 0.016 | 0.135 | Glutathione S-transferase inhibitor | 0.087 0.052 DBMET00328 | ||
| 0.172 | 0.053 | 0.197 | Thiol protease inhibitor | 0.197 0.04 DBMET00328 | DBMET00328 | |
| 0.185 | 0.068 | 0.185 | Amyloid beta precursor protein antagonist | 0.159 0.092 DBMET00328 | ||
| 0.162 | 0.045 | 0.162 | MAP kinase kinase inhibitor | |||
| 0.152 | 0.036 | 0.2 | Falcipain 3 inhibitor | 0.2 0.018 DBMET00328 | DBMET00328 | |
| 0.16 | 0.044 | 0.16 | Nav1.6 sodium channel blocker | 0.114 0.105 DBMET00328 | ||
| 0.124 | 0.008 | 0.124 | NMDA receptor glycine site agonist | 0.069 0.037 DBMET00328 | ||
| 0.126 | 0.01 | 0.126 | Purinergic P2X1 antagonist | 0.117 0.012 DBMET00328 0.085 0.023 DBMET00585 | ||
| 0.13 | 0.017 | 0.253 | Phosphodiesterase 6D inhibitor | 0.253 0.004 DBMET00585 | DBMET00585 | |
| 0.14 | 0.027 | 0.245 | Toll-Like receptor 4 antagonist | 0.245 0.004 DBMET00585 | DBMET00585 | |
| 0.163 | 0.05 | 0.163 | MAP kinase 3 inhibitor | |||
| 0.244 | 0.134 | 0.631 | Apoptosis antagonist | 0.358 0.052 DBMET00328 0.631 0.007 DBMET00585 | DBMET00585 | |
| 0.185 | 0.076 | 0.673 | Hepatoprotectant | 0.673 0.004 DBMET00585 | DBMET00585 | |
| 0.145 | 0.036 | 0.313 | DNA repair enzyme inhibitor | 0.107 0.103 DBMET00328 0.313 0.004 DBMET00585 | DBMET00585 | |
| 0.14 | 0.031 | 0.14 | Potassium channel (Ca-activated) activator | 0.098 0.057 DBMET00585 | ||
| 0.123 | 0.016 | 0.166 | Glycine receptor antagonist | 0.117 0.02 DBMET00328 0.166 0.005 DBMET00585 | DBMET00585 | |
| 0.12 | 0.013 | 0.158 | Toll-Like receptor 2 agonist | 0.036 0.034 DBMET00328 0.158 0.01 DBMET00585 | DBMET00585 | |
| 0.114 | 0.008 | 0.114 | Phospholipase D inhibitor | 0.091 0.021 DBMET00328 | ||
| 0.13 | 0.025 | 0.13 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.079 0.052 DBMET00328 | ||
| 0.141 | 0.035 | 0.148 | Caspase 3 inhibitor | 0.148 0.029 DBMET00328 | DBMET00328 | |
| 0.153 | 0.048 | 0.29 | DNA polymerase I inhibitor | 0.29 0.012 DBMET00585 | DBMET00585 | |
| 0.117 | 0.012 | 0.117 | Acetylcholine M5 receptor agonist | 0.081 0.033 DBMET00328 | ||
| 0.115 | 0.011 | 0.154 | Neuraminidase inhibitor | 0.154 0.005 DBMET00585 | DBMET00585 | |
| 0.109 | 0.005 | 0.109 | Fumarate hydratase inhibitor | 0.074 0.008 DBMET00328 0.07 0.008 DBMET00585 | ||
| 0.14 | 0.039 | 0.198 | TRPA1 agonist | 0.198 0.011 DBMET00328 | DBMET00328 | |
| 0.151 | 0.05 | 0.151 | Farnesoid X receptor antagonist | |||
| 0.107 | 0.007 | 0.117 | Exportin-1 inhibitor | 0.117 0.005 DBMET00328 | DBMET00328 | |
| 0.113 | 0.013 | 0.113 | Carbonic anhydrase VB inhibitor | |||
| 0.107 | 0.008 | 0.107 | MAP kinase kinase 7 inhibitor | 0.081 0.043 DBMET00328 | ||
| 0.117 | 0.018 | 0.137 | Na+ K+ transporting ATPase inhibitor | 0.116 0.019 DBMET00328 0.137 0.009 DBMET00585 | DBMET00585 | |
| 0.139 | 0.042 | 0.139 | Interleukin 8 antagonist | |||
| 0.134 | 0.037 | 0.423 | Mediator release inhibitor | 0.423 0.005 DBMET00585 | DBMET00585 | |
| 0.104 | 0.007 | 0.104 | Sphingosine kinase 2 inhibitor | 0.052 0.044 DBMET00328 | ||
| 0.104 | 0.008 | 0.112 | Glucosylceramidase inhibitor | 0.07 0.022 DBMET00328 0.112 0.006 DBMET00585 | DBMET00585 | |
| 0.146 | 0.05 | 0.146 | Antibacterial (Helicobacter pylori) | 0.135 0.061 DBMET00585 | ||
| 0.126 | 0.03 | 0.146 | Interleukin 1 beta converting enzyme inhibitor | 0.146 0.019 DBMET00328 0.097 0.061 DBMET00585 | DBMET00328 | |
| 0.115 | 0.02 | 0.115 | mTOR complex 2 inhibitor | 0.091 0.046 DBMET00328 | ||
| 0.117 | 0.022 | 0.117 | Bile acid receptor antagonist | 0.086 0.083 DBMET00328 | ||
| 0.101 | 0.007 | 0.101 | MDM2 inhibitor | 0.066 0.051 DBMET00328 | ||
| 0.106 | 0.013 | 0.106 | Vanilloid 4 agonist | 0.098 0.019 DBMET00328 | ||
| 0.155 | 0.062 | 0.427 | Hemostatic | 0.427 0.006 DBMET00585 | DBMET00585 | |
| 0.12 | 0.03 | 0.12 | Glutamate (mGluR7) agonist | 0.104 0.051 DBMET00328 | ||
| 0.182 | 0.092 | 0.192 | Pyruvate kinase inhibitor | 0.192 0.086 DBMET00328 | DBMET00328 | |
| 0.093 | 0.005 | 0.093 | Adenylate cyclase 1 inhibitor | 0.065 0.014 DBMET00328 | ||
| 0.109 | 0.021 | 0.109 | D-Ala-D-Ala ligase inhibitor | 0.099 0.03 DBMET00328 | ||
| 0.092 | 0.004 | 0.092 | Pregnane X receptor antagonist | 0.08 0.006 DBMET00328 0.053 0.052 DBMET00585 | ||
| 0.092 | 0.006 | 0.092 | Lysophosphatidic acid 3 receptor antagonist | 0.061 0.021 DBMET00328 | ||
| 0.114 | 0.028 | 0.114 | Macrophage migration inhibitory factor inhibitor | |||
| 0.109 | 0.023 | 0.109 | Peroxisome proliferator-activated receptor gamma agonist | |||
| 0.092 | 0.006 | 0.092 | Squalene epoxidase inhibitor | 0.059 0.021 DBMET00328 0.068 0.015 DBMET00585 | ||
| 0.129 | 0.043 | 0.274 | Xanthine oxidase inhibitor | 0.086 0.079 DBMET00328 0.274 0.01 DBMET00585 | DBMET00585 | |
| 0.094 | 0.009 | 0.094 | Diacylglycerol O-acyltransferase inhibitor | |||
| 0.099 | 0.014 | 0.099 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.093 0.019 DBMET00328 | ||
| 0.129 | 0.045 | 0.129 | Transcription factor STAT6 inhibitor | 0.103 0.097 DBMET00328 | ||
| 0.094 | 0.009 | 0.094 | Sphingosine kinase inhibitor | 0.067 0.028 DBMET00328 | ||
| 0.207 | 0.124 | 0.218 | Transcription factor STAT3 inhibitor | 0.218 0.113 DBMET00328 | DBMET00328 | |
| 0.176 | 0.093 | 0.176 | I kappa B kinase epsilon inhibitor | |||
| 0.161 | 0.079 | 0.161 | Growth hormone agonist | |||
| 0.089 | 0.007 | 0.089 | Dihydroorotate oxidase inhibitor | 0.072 0.016 DBMET00328 | ||
| 0.086 | 0.005 | 0.086 | GABA uptake inhibitor | 0.068 0.008 DBMET00328 | ||
| 0.111 | 0.03 | 0.111 | Bromodomain-containing protein 2 inhibitor | 0.09 0.055 DBMET00328 | ||
| 0.122 | 0.041 | 0.122 | Gastric antisecretory | |||
| 0.089 | 0.008 | 0.089 | Sphingosine 1-phosphate receptor 3 agonist | |||
| 0.085 | 0.005 | 0.107 | Arginase inhibitor | 0.037 0.025 DBMET00328 0.107 0.004 DBMET00585 | DBMET00585 | |
| 0.247 | 0.167 | 0.247 | 15-Lipoxygenase inhibitor | |||
| 0.089 | 0.009 | 0.089 | Calcium channel P-type blocker | 0.063 0.045 DBMET00328 | ||
| 0.215 | 0.135 | 0.263 | Hypoxia-inducible factor 1 alpha inhibitor | 0.206 0.145 DBMET00328 0.263 0.089 DBMET00585 | DBMET00585 | |
| 0.096 | 0.017 | 0.113 | Protease 3C (Human rhinovirus) inhibitor | 0.113 0.011 DBMET00328 | DBMET00328 | |
| 0.144 | 0.064 | 0.238 | Alkaline phosphatase inhibitor | 0.238 0.022 DBMET00585 | DBMET00585 | |
| 0.084 | 0.005 | 0.154 | Cytokine production stimulant | 0.053 0.023 DBMET00328 0.154 0.003 DBMET00585 | DBMET00585 | |
| 0.152 | 0.073 | 0.152 | Acetylcholine M1 receptor antagonist | |||
| 0.086 | 0.007 | 0.086 | Retinoid X alpha receptor agonist | 0.032 0.027 DBMET00328 | ||
| 0.09 | 0.011 | 0.09 | Sphingosine 1-phosphate receptor 3 antagonist | |||
| 0.091 | 0.013 | 0.091 | Phosphodiesterase 1C inhibitor | |||
| 0.082 | 0.004 | 0.082 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.06 0.007 DBMET00328 0.041 0.03 DBMET00585 | ||
| 0.081 | 0.003 | 0.082 | Uridine phosphorylase inhibitor | 0.034 0.015 DBMET00328 0.082 0.003 DBMET00585 | DBMET00585 | |
| 0.113 | 0.035 | 0.113 | Histamine N-methyltransferase inhibitor | 0.091 0.054 DBMET00328 | ||
| 0.163 | 0.085 | 0.163 | Tumour necrosis factor antagonist | |||
| 0.093 | 0.015 | 0.099 | Glutamate (mGluR7) antagonist | 0.099 0.011 DBMET00328 | DBMET00328 | |
| 0.084 | 0.008 | 0.084 | Adenosine deaminase inhibitor | 0.07 0.014 DBMET00328 0.078 0.01 DBMET00585 | ||
| 0.084 | 0.008 | 0.084 | Glutamate (mGluR4) antagonist | 0.042 0.034 DBMET00328 | ||
| 0.093 | 0.017 | 0.093 | Androgen agonist | 0.057 0.045 DBMET00328 | ||
| 0.121 | 0.045 | 0.485 | Beta glucuronidase inhibitor | 0.11 0.056 DBMET00328 0.485 0.004 DBMET00585 | DBMET00585 | |
| 0.194 | 0.119 | 0.739 | Antioxidant | 0.739 0.005 DBMET00585 | DBMET00585 | |
| 0.12 | 0.045 | 0.12 | Urease inhibitor | 0.087 0.081 DBMET00328 | ||
| 0.207 | 0.133 | 0.207 | Lipoxygenase inhibitor | |||
| 0.094 | 0.019 | 0.094 | Beta adrenoreceptor antagonist | |||
| 0.11 | 0.036 | 0.11 | Aminoacyl-tRNA synthetase inhibitor | 0.096 0.049 DBMET00585 | ||
| 0.1 | 0.027 | 0.1 | Carbonic anhydrase V inhibitor | |||
| 0.152 | 0.08 | 0.383 | Thrombolytic | 0.383 0.013 DBMET00585 | DBMET00585 | |
| 0.09 | 0.018 | 0.09 | Beta 3 adrenoreceptor antagonist | |||
| 0.079 | 0.008 | 0.079 | Retinoid X receptor agonist | 0.031 0.028 DBMET00328 | ||
| 0.075 | 0.004 | 0.077 | Guanylate cyclase inhibitor | 0.058 0.014 DBMET00328 0.077 0.003 DBMET00585 | DBMET00585 | |
| 0.076 | 0.005 | 0.076 | Geranyltranstransferase inhibitor | 0.073 0.006 DBMET00328 | ||
| 0.08 | 0.009 | 0.08 | Phosphoglycerate kinase inhibitor | 0.036 0.023 DBMET00328 0.036 0.024 DBMET00585 | ||
| 0.11 | 0.039 | 0.198 | ABCA1 expression enhancer | 0.198 0.009 DBMET00328 | DBMET00328 | |
| 0.184 | 0.114 | 0.506 | Platelet antagonist | 0.506 0.013 DBMET00585 | DBMET00585 | |
| 0.085 | 0.015 | 0.085 | Beta 1 adrenoreceptor antagonist | |||
| 0.074 | 0.005 | 0.074 | Lysophosphatidic acid 2 receptor antagonist | |||
| 0.102 | 0.033 | 0.102 | Myeloperoxidase inhibitor | |||
| 0.073 | 0.004 | 0.073 | Glutamate (mGluR8) agonist | 0.058 0.008 DBMET00328 0.035 0.033 DBMET00585 | ||
| 0.076 | 0.008 | 0.076 | Immunoglobulin Fc receptor antagonist | 0.061 0.022 DBMET00328 | ||
| 0.118 | 0.05 | 0.372 | AMP-activated protein kinase stimulant | 0.372 0.004 DBMET00585 | DBMET00585 | |
| 0.122 | 0.054 | 0.122 | GABA receptor agonist | |||
| 0.203 | 0.135 | 0.203 | Transcription factor STAT inhibitor | 0.198 0.141 DBMET00328 | ||
| 0.103 | 0.036 | 0.252 | Transcription factor NF kappa B stimulant | 0.252 0.005 DBMET00585 | DBMET00585 | |
| 0.093 | 0.025 | 0.139 | Phosphodiesterase VI inhibitor | 0.139 0.008 DBMET00585 | DBMET00585 | |
| 0.076 | 0.009 | 0.076 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.127 | 0.06 | 0.16 | Proteasome inhibitor | 0.16 0.041 DBMET00328 | DBMET00328 | |
| 0.075 | 0.008 | 0.075 | Glutamate (mGluR group III) antagonist | 0.041 0.038 DBMET00328 | ||
| 0.093 | 0.028 | 0.093 | Carbonic anhydrase VA inhibitor | |||
| 0.104 | 0.039 | 0.104 | Phosphodiesterase I inhibitor | |||
| 0.071 | 0.007 | 0.071 | Membrane dipeptidase inhibitor | 0.05 0.015 DBMET00328 | ||
| 0.154 | 0.09 | 0.154 | Antipruritic | |||
| 0.074 | 0.01 | 0.074 | Dihydroorotase inhibitor | 0.042 0.036 DBMET00328 | ||
| 0.068 | 0.005 | 0.068 | Kainate receptor agonist | 0.058 0.008 DBMET00328 0.039 0.036 DBMET00585 | ||
| 0.086 | 0.023 | 0.086 | Potassium channel (Tandem pore domain) blocker | 0.08 0.035 DBMET00328 | ||
| 0.075 | 0.013 | 0.075 | Aldosterone antagonist | |||
| 0.141 | 0.08 | 0.141 | Neuropeptide Y1 antagonist | 0.124 0.115 DBMET00328 | ||
| 0.105 | 0.043 | 0.105 | Androgen antagonist | |||
| 0.177 | 0.116 | 0.177 | Aryl hydrocarbon receptor agonist | 0.145 0.14 DBMET00328 | ||
| 0.066 | 0.006 | 0.066 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.058 0.007 DBMET00328 0.045 0.01 DBMET00585 | ||
| 0.092 | 0.032 | 0.092 | CC chemokine 5 receptor agonist | 0.088 0.04 DBMET00328 | ||
| 0.068 | 0.009 | 0.068 | Dopamine D5 agonist | 0.06 0.012 DBMET00328 | ||
| 0.115 | 0.057 | 0.115 | Protein kinase C gamma inhibitor | |||
| 0.097 | 0.039 | 0.097 | Adrenaline agonist | |||
| 0.136 | 0.078 | 0.367 | Lipid peroxidase inhibitor | 0.367 0.011 DBMET00585 | DBMET00585 | |
| 0.067 | 0.009 | 0.067 | Nicotinic acid receptor agonist | |||
| 0.063 | 0.005 | 0.164 | Sodium/glucose cotransporter 2 inhibitor | 0.164 0.001 DBMET00585 | DBMET00585 | |
| 0.066 | 0.009 | 0.078 | Neuraminidase (Influenza A) inhibitor | 0.078 0.005 DBMET00585 | DBMET00585 | |
| 0.089 | 0.032 | 0.089 | Sphingosine 1-phosphate receptor antagonist | |||
| 0.093 | 0.037 | 0.102 | Caspase 7 inhibitor | 0.102 0.026 DBMET00328 | DBMET00328 | |
| 0.063 | 0.008 | 0.063 | Sphingosine kinase 1 inhibitor | |||
| 0.06 | 0.006 | 0.06 | Retinoid X receptor antagonist | 0.04 0.024 DBMET00328 | ||
| 0.059 | 0.004 | 0.059 | Estrogen-related receptor beta antagonist | |||
| 0.066 | 0.012 | 0.066 | Thymidine kinase inhibitor | 0.039 0.031 DBMET00328 0.047 0.021 DBMET00585 | ||
| 0.057 | 0.003 | 0.057 | Lysophosphatidic acid receptor 1 agonist | 0.031 0.01 DBMET00328 | ||
| 0.071 | 0.017 | 0.071 | Nicotinic alpha3beta2 receptor antagonist | 0.052 0.04 DBMET00328 | ||
| 0.07 | 0.017 | 0.07 | Beta 2 adrenoreceptor antagonist | |||
| 0.072 | 0.019 | 0.081 | Lipocortins synthesis agonist | 0.081 0.013 DBMET00585 | DBMET00585 | |
| 0.068 | 0.016 | 0.068 | Leukotriene C antagonist | |||
| 0.078 | 0.025 | 0.13 | Xanthine dehydrogenase inhibitor | 0.13 0.009 DBMET00328 | DBMET00328 | |
| 0.068 | 0.016 | 0.068 | Purinergic P2Y antagonist | 0.064 0.017 DBMET00585 | ||
| 0.087 | 0.035 | 0.087 | Epoxide hydrolase inhibitor | |||
| 0.055 | 0.003 | 0.055 | Estrogen-related receptor gamma antagonist | 0.03 0.016 DBMET00328 | ||
| 0.061 | 0.009 | 0.061 | Retinoic acid alpha receptor agonist | |||
| 0.063 | 0.011 | 0.063 | Sphingosine 1-phosphate receptor 1 agonist | |||
| 0.127 | 0.076 | 0.127 | Nav1.2 sodium channel blocker | |||
| 0.07 | 0.019 | 0.07 | Beta 2 adrenoreceptor agonist | |||
| 0.056 | 0.005 | 0.056 | Vanilloid 3 antagonist | 0.038 0.026 DBMET00328 | ||
| 0.065 | 0.014 | 0.065 | Sphingosine 1-phosphate receptor agonist | |||
| 0.059 | 0.009 | 0.059 | Glutamate (mGluR3) antagonist | |||
| 0.101 | 0.051 | 0.101 | Potassium channel (Voltage-sensitive) activator | |||
| 0.069 | 0.019 | 0.069 | Epithelial sodium channel blocker | |||
| 0.075 | 0.026 | 0.075 | Phosphodiesterase 1B inhibitor | |||
| 0.073 | 0.025 | 0.073 | Heat shock protein 90 beta antagonist | |||
| 0.121 | 0.073 | 0.121 | Nav1.3 sodium channel blocker | 0.1 0.097 DBMET00328 | ||
| 0.084 | 0.036 | 0.084 | Calcium channel L-type blocker | |||
| 0.053 | 0.005 | 0.053 | Retinoid X alpha receptor antagonist | 0.036 0.021 DBMET00328 | ||
| 0.052 | 0.004 | 0.052 | Glutamate (mGluR3) agonist | 0.037 0.014 DBMET00328 0.032 0.023 DBMET00585 | ||
| 0.103 | 0.055 | 0.103 | Nitric-oxide synthase inhibitor | |||
| 0.05 | 0.002 | 0.05 | Lysophosphatidic acid receptor 3 agonist | 0.02 0.005 DBMET00328 | ||
| 0.052 | 0.005 | 0.058 | Ceramide glucosyltransferase inhibitor | 0.058 0.004 DBMET00585 | DBMET00585 | |
| 0.052 | 0.005 | 0.052 | Glutamate (mGluR1a) agonist | 0.041 0.005 DBMET00328 | ||
| 0.151 | 0.104 | 0.548 | Platelet adhesion inhibitor | 0.548 0.005 DBMET00585 | DBMET00585 | |
| 0.086 | 0.04 | 0.086 | Estrogen receptor alpha antagonist | |||
| 0.067 | 0.02 | 0.067 | Sphingosine 1-phosphate receptor 1 antagonist | |||
| 0.059 | 0.012 | 0.059 | Dihydropteroate synthase inhibitor | |||
| 0.071 | 0.025 | 0.071 | Potassium channel intermediate-conductance Ca-activated blocker | 0.067 0.03 DBMET00328 | ||
| 0.055 | 0.008 | 0.055 | MAP3K5 inhibitor | |||
| 0.077 | 0.031 | 0.077 | Potassium channel (ATP-sensitive) blocker | |||
| 0.066 | 0.02 | 0.114 | Adenine nucleotide translocase inhibitor | 0.114 0.004 DBMET00585 | DBMET00585 | |
| 0.094 | 0.049 | 0.129 | ATPase (Vacuolar H+) inhibitor | 0.129 0.014 DBMET00585 | DBMET00585 | |
| 0.08 | 0.034 | 0.08 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.067 | 0.022 | 0.067 | Ryanodine receptor antagonist | 0.062 0.032 DBMET00328 | ||
| 0.075 | 0.031 | 0.075 | 5 Hydroxytryptamine 3 agonist | 0.059 0.05 DBMET00328 | ||
| 0.064 | 0.02 | 0.064 | Topoisomerase II beta inhibitor | |||
| 0.049 | 0.005 | 0.214 | Sodium/glucose cotransporter inhibitor | 0.214 0.001 DBMET00585 | DBMET00585 | |
| 0.057 | 0.014 | 0.057 | GABA B receptor antagonist | |||
| 0.109 | 0.066 | 0.109 | Chelator | |||
| 0.069 | 0.026 | 0.069 | Phosphodiesterase 1A inhibitor | |||
| 0.073 | 0.03 | 0.073 | NMDA 2C receptor antagonist | |||
| 0.086 | 0.044 | 0.097 | Nicotinic alpha4beta2 receptor antagonist | 0.097 0.034 DBMET00328 | DBMET00328 | |
| 0.09 | 0.048 | 0.09 | Inducible nitric-oxide synthase inhibitor | |||
| 0.047 | 0.005 | 0.047 | Glutamate (mGluR1) agonist | 0.028 0.012 DBMET00328 | ||
| 0.051 | 0.009 | 0.051 | Free fatty acid receptor 1 antagonist | |||
| 0.046 | 0.004 | 0.046 | Purinergic P2Y15 antagonist | 0.041 0.007 DBMET00328 0.031 0.015 DBMET00585 | ||
| 0.062 | 0.02 | 0.288 | Heparanase inhibitor | 0.054 0.034 DBMET00328 0.288 0.002 DBMET00585 | DBMET00585 | |
| 0.044 | 0.003 | 0.044 | Carbonic anhydrase X inhibitor | 0.029 0.004 DBMET00328 | ||
| 0.044 | 0.003 | 0.044 | Carbonic anhydrase VIII inhibitor | 0.029 0.004 DBMET00328 | ||
| 0.059 | 0.018 | 0.059 | Oxytocin agonist | 0.051 0.023 DBMET00328 | ||
| 0.074 | 0.033 | 0.074 | Aryl hydrocarbon receptor antagonist | |||
| 0.057 | 0.016 | 0.057 | Glutamate (mGluR1a) antagonist | |||
| 0.064 | 0.023 | 0.064 | Thromboxane synthase inhibitor | |||
| 0.045 | 0.005 | 0.045 | Prostaglandin F2 alpha agonist | 0.023 0.014 DBMET00328 0.023 0.015 DBMET00585 | ||
| 0.071 | 0.03 | 0.079 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.079 0.025 DBMET00585 | DBMET00585 | |
| 0.069 | 0.029 | 0.076 | Cyclin D1 inhibitor | 0.076 0.022 DBMET00328 | DBMET00328 | |
| 0.114 | 0.074 | 0.201 | Beta amyloid protein antagonist | 0.201 0.016 DBMET00585 | DBMET00585 | |
| 0.142 | 0.102 | 0.208 | Interleukin 6 antagonist | 0.208 0.036 DBMET00585 | DBMET00585 | |
| 0.121 | 0.082 | 0.169 | NADPH oxidase inhibitor | 0.169 0.045 DBMET00328 0.106 0.103 DBMET00585 | DBMET00328 | |
| 0.07 | 0.031 | 0.07 | Carbonic anhydrase stimulant | 0.058 0.043 DBMET00328 | ||
| 0.107 | 0.068 | 0.141 | 5 Hydroxytryptamine 3A agonist | 0.141 0.04 DBMET00328 | DBMET00328 | |
| 0.063 | 0.025 | 0.063 | Peroxisome proliferator-activated receptor alpha agonist | |||
| 0.057 | 0.019 | 0.057 | Dopamine beta hydroxylase inhibitor | 0.055 0.021 DBMET00328 | ||
| 0.059 | 0.021 | 0.059 | Potassium channel (Inward rectifier) activator | 0.052 0.031 DBMET00328 | ||
| 0.054 | 0.016 | 0.054 | Calcitonin receptor agonist | 0.031 0.026 DBMET00328 | ||
| 0.075 | 0.038 | 0.075 | Protein kinase C beta inhibitor | 0.063 0.062 DBMET00328 0.068 0.051 DBMET00585 | ||
| 0.052 | 0.015 | 0.052 | Angiotensin AT1 receptor antagonist | |||
| 0.061 | 0.024 | 0.061 | Sphingosine 1-phosphate receptor 5 agonist | |||
| 0.08 | 0.044 | 0.122 | Cathepsin G inhibitor | 0.122 0.027 DBMET00328 | DBMET00328 | |
| 0.105 | 0.069 | 0.105 | CDC-like kinase 3 inhibitor | |||
| 0.056 | 0.02 | 0.056 | Potassium channel (ATP-sensitive) activator | 0.05 0.03 DBMET00328 | ||
| 0.079 | 0.044 | 0.079 | Adenosine A3 receptor antagonist | |||
| 0.06 | 0.025 | 0.153 | Carbonic anhydrase XIV inhibitor | 0.153 0.005 DBMET00585 | DBMET00585 | |
| 0.04 | 0.005 | 0.04 | Nicotinic acid receptor 2 antagonist | 0.032 0.01 DBMET00328 | ||
| 0.045 | 0.01 | 0.045 | Melatonin receptor 1A agonist | 0.035 0.021 DBMET00328 | ||
| 0.044 | 0.01 | 0.044 | Tryptophan 5 hydroxylase inhibitor | 0.034 0.032 DBMET00328 | ||
| 0.061 | 0.027 | 0.081 | Leukotriene B4 antagonist | 0.081 0.015 DBMET00585 | DBMET00585 | |
| 0.049 | 0.015 | 0.049 | Diamine oxidase inhibitor | |||
| 0.093 | 0.06 | 0.093 | Protein kinase C zeta inhibitor | |||
| 0.057 | 0.023 | 0.057 | Potassium channel Kv1.3 blocker | 0.042 0.039 DBMET00328 | ||
| 0.043 | 0.01 | 0.043 | Cholesterol ester transfer protein antagonist | |||
| 0.037 | 0.005 | 0.052 | Vanilloid 2 agonist | 0.034 0.006 DBMET00328 0.052 0.003 DBMET00585 | DBMET00585 | |
| 0.042 | 0.01 | 0.042 | Lysine carboxypeptidase inhibitor | |||
| 0.049 | 0.016 | 0.049 | Vascular adhesion protein 1 inhibitor | |||
| 0.036 | 0.004 | 0.036 | Neuraminidase (Influenza B) inhibitor | 0.022 0.011 DBMET00328 0.026 0.007 DBMET00585 | ||
| 0.049 | 0.017 | 0.049 | Kainate receptor 2 antagonist | |||
| 0.119 | 0.086 | 0.119 | Toll-Like receptor antagonist | |||
| 0.037 | 0.005 | 0.037 | Hedgehog signaling activator | 0.031 0.012 DBMET00328 | ||
| 0.035 | 0.004 | 0.035 | Isoleucine-tRNA ligase inhibitor | 0.023 0.015 DBMET00328 0.033 0.004 DBMET00585 | ||
| 0.045 | 0.014 | 0.045 | CF transmembrane conductance regulator antagonist | |||
| 0.046 | 0.014 | 0.046 | Leukotriene C4 antagonist | |||
| 0.086 | 0.055 | 0.086 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | |||
| 0.085 | 0.055 | 0.085 | Histamine H2 receptor antagonist | |||
| 0.064 | 0.034 | 0.064 | Ribonucleotide reductase inhibitor | 0.053 0.04 DBMET00328 | ||
| 0.138 | 0.108 | 0.588 | Nitric oxide antagonist | 0.157 0.09 DBMET00328 0.588 0.01 DBMET00585 | DBMET00585 | |
| 0.057 | 0.027 | 0.065 | Antimetabolite | 0.046 0.034 DBMET00328 0.065 0.023 DBMET00585 | DBMET00585 | |
| 0.07 | 0.04 | 0.071 | Leukotriene antagonist | 0.071 0.039 DBMET00585 | DBMET00585 | |
| 0.154 | 0.124 | 0.154 | Focal adhesion kinase 2 inhibitor | |||
| 0.047 | 0.017 | 0.047 | Farnesoid X receptor agonist | |||
| 0.045 | 0.015 | 0.045 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | |||
| 0.048 | 0.018 | 0.061 | Alpha 1d adrenoreceptor agonist | 0.061 0.01 DBMET00328 | DBMET00328 | |
| 0.062 | 0.033 | 0.062 | Ribonucleoside-diphosphate reductase inhibitor | 0.053 0.039 DBMET00328 | ||
| 0.036 | 0.007 | 0.036 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.026 0.02 DBMET00328 | ||
| 0.065 | 0.036 | 0.065 | Corticotropin releasing factor 2 receptor antagonist | 0.062 0.042 DBMET00328 | ||
| 0.033 | 0.004 | 0.033 | Retinoid X beta receptor antagonist | 0.023 0.009 DBMET00328 | ||
| 0.056 | 0.027 | 0.056 | Bombesin 2 receptor antagonist | |||
| 0.04 | 0.012 | 0.04 | Adenosine uptake inhibitor | |||
| 0.084 | 0.056 | 0.084 | GABA A receptor agonist | |||
| 0.038 | 0.009 | 0.038 | Prostaglandin EP2 agonist | |||
| 0.036 | 0.008 | 0.036 | Thymidine phosphorylase inhibitor | 0.024 0.022 DBMET00328 | ||
| 0.078 | 0.05 | 0.127 | CYP2A6 inhibitor | 0.127 0.024 DBMET00328 | DBMET00328 | |
| 0.047 | 0.019 | 0.047 | Heme oxygenase inhibitor | 0.041 0.037 DBMET00328 | ||
| 0.039 | 0.012 | 0.039 | Methionyl aminopeptidase 1 inhibitor | |||
| 0.052 | 0.025 | 0.052 | Thymidylate synthase inhibitor | 0.051 0.026 DBMET00328 | ||
| 0.04 | 0.013 | 0.04 | Prostaglandin agonist | |||
| 0.055 | 0.028 | 0.055 | Potassium channel (Inward rectifier) blocker | |||
| 0.032 | 0.006 | 0.032 | Fructose-1,6-bisphosphatase 1 inhibitor | |||
| 0.039 | 0.013 | 0.039 | Liver X receptor beta antagonist | |||
| 0.054 | 0.028 | 0.054 | CD45 antagonist | |||
| 0.048 | 0.022 | 0.048 | Beta adrenoreceptor agonist | |||
| 0.034 | 0.009 | 0.034 | Thyroid hormone agonist | |||
| 0.029 | 0.003 | 0.039 | Telomerase stimulant | 0.023 0.005 DBMET00328 0.039 0.002 DBMET00585 | DBMET00585 | |
| 0.029 | 0.004 | 0.059 | Antibiotic Anthracycline-like | 0.019 0.012 DBMET00328 0.059 0.001 DBMET00585 | DBMET00585 | |
| 0.053 | 0.028 | 0.149 | Phosphorylase inhibitor | 0.149 0.007 DBMET00585 | DBMET00585 | |
| 0.063 | 0.038 | 0.063 | Cyclin-dependent kinase 6 inhibitor | |||
| 0.072 | 0.047 | 0.072 | Secretase beta inhibitor | |||
| 0.041 | 0.016 | 0.041 | Peroxisome proliferator-activated receptor delta agonist | |||
| 0.042 | 0.018 | 0.042 | Integrin alpha2 antagonist | |||
| 0.039 | 0.015 | 0.039 | Angiotensin II receptor antagonist | |||
| 0.034 | 0.01 | 0.034 | CXC chemokine 2 receptor antagonist | |||
| 0.107 | 0.082 | 0.107 | Estrogen antagonist | |||
| 0.084 | 0.06 | 0.084 | Vanilloid agonist | |||
| 0.042 | 0.018 | 0.042 | Delayed rectifier potassium channel blocker | |||
| 0.028 | 0.005 | 0.028 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.02 0.015 DBMET00328 | ||
| 0.027 | 0.005 | 0.027 | Estrogen-related receptor gamma agonist | |||
| 0.028 | 0.005 | 0.028 | Toll-Like receptor 8 agonist | |||
| 0.026 | 0.004 | 0.027 | Methylmalonyl-CoA mutase inhibitor | 0.027 0.003 DBMET00328 0.021 0.007 DBMET00585 | DBMET00328 | |
| 0.05 | 0.028 | 0.05 | CC chemokine 4 receptor antagonist | |||
| 0.047 | 0.025 | 0.055 | Histamine H2 receptor agonist | 0.055 0.018 DBMET00328 | DBMET00328 | |
| 0.023 | 0.002 | 0.023 | Mannitol 2-dehydrogenase inhibitor | |||
| 0.027 | 0.006 | 0.027 | Retinoic acid beta receptor agonist | |||
| 0.127 | 0.107 | 0.127 | Cyclin-dependent kinase 8 inhibitor | |||
| 0.115 | 0.094 | 0.115 | Cytokine production inhibitor | |||
| 0.03 | 0.01 | 0.03 | Retinoic acid receptor agonist | |||
| 0.086 | 0.066 | 0.086 | Potassium channel activator | |||
| 0.043 | 0.022 | 0.043 | AMPA 4 receptor antagonist | |||
| 0.034 | 0.013 | 0.034 | Nicotinic alpha4beta2 receptor agonist | 0.032 0.015 DBMET00328 | ||
| 0.054 | 0.033 | 0.054 | Thromboxane A2 antagonist | |||
| 0.047 | 0.026 | 0.066 | AICAR transformylase inhibitor | 0.066 0.011 DBMET00328 | DBMET00328 | |
| 0.024 | 0.004 | 0.024 | Thromboxane A2 agonist | 0.018 0.007 DBMET00328 | ||
| 0.031 | 0.011 | 0.031 | Integrin alpha2beta1 antagonist | |||
| 0.037 | 0.017 | 0.037 | Acetylcholine M4 receptor agonist | |||
| 0.056 | 0.036 | 0.056 | Thromboxane antagonist | |||
| 0.05 | 0.03 | 0.05 | Cholesterol esterase inhibitor | |||
| 0.056 | 0.037 | 0.056 | Acetylcholine muscarinic agonist | |||
| 0.029 | 0.01 | 0.029 | Acid ceramidase inhibitor | 0.026 0.017 DBMET00328 | ||
| 0.032 | 0.013 | 0.032 | Methionyl aminopeptidase 2 inhibitor | |||
| 0.027 | 0.008 | 0.027 | Retinoic acid gamma receptor agonist | |||
| 0.083 | 0.064 | 0.083 | Hematopoietic | |||
| 0.104 | 0.086 | 0.104 | Acetylcholine muscarinic antagonist | |||
| 0.176 | 0.158 | 0.223 | 5 Hydroxytryptamine 1E antagonist | 0.223 0.105 DBMET00328 | DBMET00328 | |
| 0.036 | 0.018 | 0.036 | Peroxisome proliferator-activated receptor delta antagonist | |||
| 0.03 | 0.012 | 0.03 | Retinoid X gamma receptor antagonist | |||
| 0.06 | 0.043 | 0.06 | Cannabinoid CB1 receptor agonist | |||
| 0.051 | 0.034 | 0.057 | Prolyl endopeptidase inhibitor | 0.057 0.027 DBMET00328 | DBMET00328 | |
| 0.037 | 0.02 | 0.037 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | |||
| 0.043 | 0.026 | 0.043 | Kainate receptor antagonist | |||
| 0.052 | 0.035 | 0.052 | Dihydroorotate dehydrogenase inhibitor | |||
| 0.023 | 0.007 | 0.043 | Ileal bile acid transport inhibitor | 0.043 0.004 DBMET00585 | DBMET00585 | |
| 0.042 | 0.027 | 0.042 | Liver X receptor alpha agonist | |||
| 0.043 | 0.028 | 0.048 | Nerve growth factor antagonist | 0.048 0.02 DBMET00328 | DBMET00328 | |
| 0.039 | 0.024 | 0.039 | 5-Alpha-reductase inhibitor | |||
| 0.06 | 0.045 | 0.068 | Transcription factor AP-1 inhibitor | 0.068 0.032 DBMET00585 | DBMET00585 | |
| 0.025 | 0.011 | 0.025 | ICAM 1 antagonist | |||
| 0.059 | 0.044 | 0.059 | Acetylcholine M5 receptor antagonist | |||
| 0.029 | 0.015 | 0.029 | Myristoyl transferase inhibitor | |||
| 0.02 | 0.006 | 0.02 | Purinergic P2Y1 agonist | 0.016 0.01 DBMET00328 0.015 0.012 DBMET00585 | ||
| 0.018 | 0.004 | 0.018 | Glutamate (mGluR6) agonist | 0.012 0.008 DBMET00328 | ||
| 0.02 | 0.006 | 0.02 | Vitamin D receptor agonist | 0.02 0.007 DBMET00585 | ||
| 0.058 | 0.044 | 0.058 | Collagenase 3 inhibitor | |||
| 0.026 | 0.013 | 0.026 | Prostaglandin E2 agonist | |||
| 0.03 | 0.016 | 0.03 | LFA antagonist | |||
| 0.055 | 0.042 | 0.055 | Fatty acid synthase inhibitor | |||
| 0.035 | 0.022 | 0.035 | Calcium-independent phospholipase A2 inhibitor | |||
| 0.028 | 0.016 | 0.028 | Calcium-sensing receptor agonist | |||
| 0.085 | 0.073 | 0.221 | Uric acid excretion stimulant | 0.221 0.01 DBMET00585 | DBMET00585 | |
| 0.033 | 0.021 | 0.033 | ATP citrate lysase inhibitor | |||
| 0.048 | 0.036 | 0.059 | HCV NS3/NS4A protease inhibitor | 0.059 0.022 DBMET00328 | DBMET00328 | |
| 0.115 | 0.103 | 0.133 | Neurotrophic factor | 0.128 0.083 DBMET00328 0.133 0.076 DBMET00585 | DBMET00585 | |
| 0.034 | 0.022 | 0.034 | Carboxypeptidase B inhibitor | |||
| 0.069 | 0.058 | 0.069 | CDC25A inhibitor | |||
| 0.02 | 0.009 | 0.02 | Nicotinic acid receptor 1 antagonist | |||
| 0.027 | 0.016 | 0.027 | Prostaglandin H2 antagonist | |||
| 0.042 | 0.031 | 0.044 | Leukocyte elastase inhibitor | 0.044 0.028 DBMET00328 | DBMET00328 | |
| 0.016 | 0.005 | 0.016 | Carbonic anhydrase XI inhibitor | 0.013 0.009 DBMET00328 | ||
| 0.02 | 0.01 | 0.02 | Alpha 2b adrenoreceptor agonist | 0.02 0.01 DBMET00328 | ||
| 0.015 | 0.005 | 0.015 | Thromboxane agonist | |||
| 0.061 | 0.051 | 0.065 | Transcription factor RelA inhibitor | 0.065 0.039 DBMET00328 | DBMET00328 | |
| 0.033 | 0.023 | 0.033 | Protein kinase (CK2) beta inhibitor | |||
| 0.016 | 0.005 | 0.016 | Cyclin D2 inhibitor | |||
| 0.027 | 0.018 | 0.027 | Kynurenine 3 monooxygenase inhibitor | |||
| 0.02 | 0.011 | 0.02 | Cyclin T1 inhibitor | |||
| 0.02 | 0.011 | 0.02 | Follicle-stimulating hormone antagonist | |||
| 0.015 | 0.006 | 0.015 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.015 0.007 DBMET00328 | ||
| 0.037 | 0.027 | 0.037 | G protein-coupled receptor agonist | |||
| 0.045 | 0.036 | 0.045 | Phosphodiesterase 6C inhibitor | |||
| 0.037 | 0.028 | 0.037 | TRPM8 blocker | |||
| 0.034 | 0.024 | 0.034 | Carnitine palmitoyltransferase 1 inhibitor | |||
| 0.031 | 0.022 | 0.031 | Prostaglandin D2 agonist | |||
| 0.019 | 0.01 | 0.019 | CXC chemokine 5 receptor antagonist | |||
| 0.024 | 0.015 | 0.024 | Retinoid X gamma receptor agonist | |||
| 0.019 | 0.01 | 0.019 | G-protein-coupled receptor 120 agonist | |||
| 0.104 | 0.095 | 0.104 | M17 leucyl aminopeptidase inhibitor | |||
| 0.033 | 0.024 | 0.033 | Liver X receptor beta agonist | |||
| 0.033 | 0.024 | 0.033 | Carnitine palmitoyltransferase inhibitor | |||
| 0.042 | 0.033 | 0.042 | Stearoyl-CoA desaturase inhibitor | |||
| 0.037 | 0.028 | 0.037 | NMDA receptor subunit 3A antagonist | |||
| 0.059 | 0.05 | 0.541 | Selectin antagonist | 0.541 0.002 DBMET00585 | DBMET00585 | |
| 0.026 | 0.017 | 0.029 | Complement factor 1s inhibitor | 0.029 0.01 DBMET00328 | DBMET00328 | |
| 0.024 | 0.015 | 0.024 | Purinergic P2Y12 antagonist | |||
| 0.03 | 0.022 | 0.03 | Peptide deformylase inhibitor | 0.027 0.025 DBMET00328 | ||
| 0.022 | 0.014 | 0.022 | Retinoid X beta receptor agonist | |||
| 0.031 | 0.023 | 0.031 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.017 | 0.01 | 0.017 | Adenosine A2 receptor agonist | |||
| 0.022 | 0.014 | 0.022 | Lysophosphatidic acid 1 receptor antagonist | |||
| 0.246 | 0.239 | 0.246 | MAP kinase 1 inhibitor | |||
| 0.042 | 0.035 | 0.042 | Dihydrofolate reductase inhibitor | |||
| 0.053 | 0.046 | 0.053 | Adenosine A1 receptor antagonist | |||
| 0.129 | 0.122 | 0.129 | LIM domain kinase 1 inhibitor | |||
| 0.03 | 0.023 | 0.03 | Epoxide hydrolase 1 inhibitor | 0.03 0.023 DBMET00328 | ||
| 0.045 | 0.039 | 0.045 | Metalloproteinase-3 inhibitor | |||
| 0.016 | 0.01 | 0.016 | Prostaglandin EP4 agonist | |||
| 0.02 | 0.014 | 0.021 | Caspase 8 inhibitor | 0.021 0.011 DBMET00328 | DBMET00328 | |
| 0.049 | 0.043 | 0.049 | Toll-Like receptor 8 antagonist | |||
| 0.079 | 0.073 | 0.079 | Interleukin-1 receptor-associated protein kinase 4 inhibitor | |||
| 0.057 | 0.052 | 0.057 | Prostaglandin F2 alpha antagonist | |||
| 0.04 | 0.035 | 0.04 | NMDA receptor subunit 3B antagonist | |||
| 0.049 | 0.044 | 0.049 | Vanilloid 2 antagonist | |||
| 0.016 | 0.01 | 0.016 | NMDA receptor phencyclidine site antagonist | |||
| 0.012 | 0.007 | 0.012 | Purine nucleoside phosphorylase inhibitor | |||
| 0.036 | 0.031 | 0.036 | Urate transporter 1 inhibitor | |||
| 0.034 | 0.029 | 0.099 | Antibiotic Aminoglycoside-like | 0.099 0.003 DBMET00585 | DBMET00585 | |
| 0.039 | 0.034 | 0.039 | Acetylcholine M1 receptor agonist | |||
| 0.034 | 0.03 | 0.034 | Factor XIIIa inhibitor | |||
| 0.049 | 0.044 | 0.049 | Maillard reaction inhibitor | |||
| 0.026 | 0.022 | 0.029 | Glucosylceramidase stimulant | 0.029 0.013 DBMET00328 | DBMET00328 | |
| 0.024 | 0.02 | 0.024 | Prostaglandin EP4 antagonist | |||
| 0.032 | 0.028 | 0.032 | Purinergic P2X3 antagonist | |||
| 0.033 | 0.03 | 0.033 | Potassium channel KCNQ activator | |||
| 0.033 | 0.03 | 0.033 | Delayed rectifier potassium channel activator | |||
| 0.021 | 0.018 | 0.022 | Vitamin D receptor antagonist | 0.022 0.014 DBMET00585 | DBMET00585 | |
| 0.014 | 0.011 | 0.014 | Adenosine A2a receptor agonist | |||
| 0.006 | 0.004 | 0.006 | Transcortin receptor antagonist | |||
| 0.055 | 0.052 | 0.055 | 5 Hydroxytryptamine 2A agonist | |||
| 0.022 | 0.02 | 0.022 | Phosphodiesterase 6A inhibitor | |||
| 0.029 | 0.027 | 0.029 | Sirtuin 2 inhibitor | |||
| 0.031 | 0.029 | 0.031 | RNA-directed RNA polymerase inhibitor | |||
| 0.005 | 0.003 | 0.005 | Reverse transcriptase (HBV) inhibitor | |||
| 0.082 | 0.08 | 0.082 | Polo-like kinase-1 inhibitor | |||
| 0.035 | 0.033 | 0.045 | Potassium channel Kv1.1 blocker | 0.045 0.017 DBMET00328 | DBMET00328 | |
| 0.075 | 0.073 | 0.075 | Antineoplastic alkaloid | |||
| 0.017 | 0.016 | 0.017 | Complement factor D inhibitor | |||
| 0.038 | 0.037 | 0.038 | Glutamate (mGluR group III) agonist | |||
| 0.021 | 0.019 | 0.021 | Beta 1 adrenoreceptor agonist | |||
| 0.057 | 0.056 | 0.093 | CDC25B inhibitor | 0.093 0.019 DBMET00328 | DBMET00328 | |
| 0.058 | 0.057 | 0.058 | Histone deacetylase SIRT3 inhibitor | 0.058 0.056 DBMET00328 | ||
| 0.01 | 0.009 | 0.014 | Purinergic P2Y2 agonist | 0.014 0.004 DBMET00585 | DBMET00585 | |
| 0.123 | 0.122 | 0.124 | Heat shock protein 90 alpha antagonist | 0.124 0.12 DBMET00328 | DBMET00328 | |
| 0.118 | 0.117 | 0.118 | Heat shock protein 90 antagonist | |||
| 0.008 | 0.007 | 0.008 | Thyroid hormone beta agonist | |||
| 0.027 | 0.026 | 0.027 | MAP3K8 inhibitor | |||
| 0.007 | 0.006 | 0.007 | DNA topoisomerase III inhibitor | 0.007 0.005 DBMET00328 | ||
| 0.015 | 0.014 | 0.018 | Nicotinic alpha4 receptor agonist | 0.018 0.009 DBMET00328 | DBMET00328 | |
| 0.019 | 0.019 | 0.032 | Corticosteroid-like | 0.032 0.006 DBMET00585 | DBMET00585 | |
| 0.04 | 0.041 | 0.049 | Histamine H1 receptor agonist | 0.049 0.02 DBMET00328 | DBMET00328 | |
| 0.045 | 0.049 | 0.052 | Factor III inhibitor | 0.052 0.03 DBMET00585 | DBMET00585 | |
| 0.025 | 0.03 | 0.03 | Nicotinic alpha3beta4 receptor agonist | 0.03 0.021 DBMET00328 | DBMET00328 | |
| 0.02 | 0.027 | 0.026 | Leukotriene B4 receptor 1 antagonist | 0.026 0.021 DBMET00585 | DBMET00585 | |
| 0.035 | 0.046 | 0.04 | Nicotinic receptor alpha3 subunit antagonist | 0.04 0.036 DBMET00328 | DBMET00328 | |
| 0.023 | 0.036 | 0.028 | Potassium channel small-conductance Ca-activated activator | 0.028 0.026 DBMET00328 | DBMET00328 | |
| 0.02 | 0.035 | 0.068 | Squalene synthetase inhibitor | 0.068 0.01 DBMET00585 | DBMET00585 | |
| 0.204 | 0.218 | 0.668 | Alpha-glucosidase inhibitor | 0.668 0.04 DBMET00585 | DBMET00585 | |
| 0.088 | 0.105 | 0.534 | Factor V inhibitor | 0.534 0.001 DBMET00328 | DBMET00328 | |
| 0.015 | 0.033 | 0.027 | Leukotriene B4 receptor 2 antagonist | 0.027 0.01 DBMET00585 | DBMET00585 | |
| 0.007 | 0.025 | 0.015 | Immunosuppressant Cyclosporine-like | 0.015 0.005 DBMET00328 | DBMET00328 | |
| 0.035 | 0.053 | 0.049 | Glutamate (mGluR group I) agonist | 0.049 0.031 DBMET00328 | DBMET00328 | |
| 0.05 | 0.069 | 0.091 | Nitric oxide donor | 0.091 0.014 DBMET00585 | DBMET00585 | |
| 0.01 | 0.029 | 0.015 | S-adenosyl-L-homocysteine hydrolase inhibitor | 0.015 0.01 DBMET00585 | DBMET00585 | |
| 0.058 | 0.078 | 0.277 | Topoisomerase II alpha inhibitor | 0.277 0.009 DBMET00585 | DBMET00585 | |
| 0.012 | 0.033 | 0.017 | Alpha 2c adrenoreceptor agonist | 0.017 0.015 DBMET00328 | DBMET00328 | |
| 0.015 | 0.039 | 0.042 | Somatostatin 5 antagonist | 0.042 0.017 DBMET00585 | DBMET00585 | |
| 0.038 | 0.065 | 0.126 | Factor IXa inhibitor | 0.126 0.005 DBMET00585 | DBMET00585 | |
| 0.04 | 0.069 | 0.074 | Carbonic anhydrase inhibitor | 0.074 0.038 DBMET00585 | DBMET00585 | |
| 0.038 | 0.069 | 0.07 | Prostaglandin EP2 antagonist | 0.07 0.033 DBMET00585 | DBMET00585 | |
| 0.049 | 0.083 | 0.211 | Caspase 9 inhibitor | 0.211 0.004 DBMET00328 | DBMET00328 | |
| 0.134 | 0.169 | 0.676 | Free radical scavenger | 0.676 0.005 DBMET00585 | DBMET00585 | |
| 0.05 | 0.087 | 0.177 | Amidase inhibitor | 0.177 0.007 DBMET00328 | DBMET00328 | |
| 0.037 | 0.074 | 0.062 | Cathepsin L inhibitor | 0.062 0.036 DBMET00328 | DBMET00328 | |
| 0.011 | 0.05 | 0.022 | Adenosine A1 receptor agonist | 0.022 0.02 DBMET00585 | DBMET00585 | |
| 0.075 | 0.116 | 0.09 | Interleukin 12 antagonist | 0.09 0.072 DBMET00585 | DBMET00585 | |
| 0.131 | 0.172 | 0.369 | Antiamyloidogenic | 0.369 0.035 DBMET00585 | DBMET00585 | |
| 0.03 | 0.074 | 0.062 | Microtubule stabilization | 0.062 0.012 DBMET00585 | DBMET00585 | |
| 0.064 | 0.108 | 0.13 | Protease inhibitor | 0.13 0.041 DBMET00328 | DBMET00328 | |
| 0.018 | 0.065 | 0.033 | 1,3-Beta-glucan synthase inhibitor | 0.033 0.009 DBMET00585 | DBMET00585 | |
| 0.069 | 0.116 | 0.448 | 3C-Like protease (SARS coronavirus) inhibitor | 0.448 0.002 DBMET00328 | DBMET00328 | |
| 0.022 | 0.07 | 0.093 | Carbonic anhydrase XII inhibitor | 0.093 0.021 DBMET00585 | DBMET00585 | |
| 0.022 | 0.072 | 0.077 | Carbonic anhydrase IX inhibitor | 0.077 0.029 DBMET00585 | DBMET00585 | |
| 0.015 | 0.064 | 0.053 | Caspase 2 inhibitor | 0.053 0.011 DBMET00328 | DBMET00328 | |
| 0.098 | 0.148 | 0.2 | Protein-tyrosine phosphatase inhibitor | 0.2 0.046 DBMET00585 | DBMET00585 | |
| 0.003 | 0.053 | 0.014 | Purinergic P2 agonist | 0.014 0.011 DBMET00585 | DBMET00585 | |
| 0.003 | 0.053 | 0.014 | Purinergic receptor agonist | 0.014 0.011 DBMET00585 | DBMET00585 | |
| 0.019 | 0.069 | 0.04 | Cathepsin L1 inhibitor | 0.04 0.027 DBMET00328 | DBMET00328 | |
| 0.07 | 0.12 | 0.202 | Protein-tyrosine phosphatase 1B inhibitor | 0.202 0.029 DBMET00585 | DBMET00585 | |
| 0.019 | 0.072 | 0.058 | Toll-Like receptor 4 agonist | 0.058 0.003 DBMET00585 | DBMET00585 | |
| 0.008 | 0.062 | 0.018 | Inosine monophosphate dehydrogenase 1 inhibitor | 0.018 0.016 DBMET00585 | DBMET00585 | |
| 0.02 | 0.074 | 0.038 | Caspase 6 inhibitor | 0.038 0.009 DBMET00328 | DBMET00328 | |
| 0.117 | 0.172 | 0.167 | P-glycoprotein inhibitor | 0.167 0.093 DBMET00585 | DBMET00585 | |
| 0.159 | 0.219 | 0.708 | Immunomodulator | 0.708 0.005 DBMET00585 | DBMET00585 | |
| 0.013 | 0.073 | 0.079 | Protein 30S ribosomal subunit inhibitor | 0.079 0.004 DBMET00585 | DBMET00585 | |
| 0.018 | 0.082 | 0.045 | Estrogen agonist | 0.045 0.038 DBMET00585 | DBMET00585 | |
| 0.037 | 0.104 | 0.287 | Antineoplastic antibiotic | 0.287 0.01 DBMET00585 | DBMET00585 | |
| 0.033 | 0.104 | 0.087 | TRPA1 antagonist | 0.087 0.022 DBMET00328 | DBMET00328 | |
| 0.026 | 0.098 | 0.173 | Protein 50S ribosomal subunit inhibitor | 0.173 0.005 DBMET00328 0.162 0.006 DBMET00585 | DBMET00328 | |
| 0.002 | 0.079 | 0.021 | Antibiotic Macrolide-like | 0.021 0.006 DBMET00328 0.021 0.006 DBMET00585 | DBMET00585 | |
| 0.078 | 0.158 | 0.476 | Cell adhesion inhibitor | 0.476 0.004 DBMET00585 | DBMET00585 | |
| 0.013 | 0.097 | 0.035 | Trypsin II inhibitor | 0.035 0.016 DBMET00328 | DBMET00328 | |
| 0.196 | 0.282 | 0.872 | Cyclophilin D inhibitor | 0.872 0.005 DBMET00585 | DBMET00585 | |
| 0.02 | 0.114 | 0.079 | Aldose reductase inhibitor | 0.079 0.024 DBMET00585 | DBMET00585 | |
| 0.051 | 0.147 | 0.389 | Cell adhesion molecule inhibitor | 0.389 0.005 DBMET00585 | DBMET00585 | |
| 0.046 | 0.153 | 0.349 | Topoisomerase I inhibitor | 0.349 0.008 DBMET00585 | DBMET00585 | |
| 0.02 | 0.128 | 0.096 | Plasminogen activator inhibitor | 0.096 0.018 DBMET00328 | DBMET00328 | |
| 0.025 | 0.14 | 0.053 | Human rhinovirus A protease inhibitor | 0.053 0.04 DBMET00328 | DBMET00328 | |
| 0.058 | 0.174 | 0.103 | Thioredoxin reductase inhibitor | 0.103 0.026 DBMET00328 | DBMET00328 | |
| 0.05 | 0.171 | 0.322 | Topoisomerase II inhibitor | 0.322 0.015 DBMET00585 | DBMET00585 | |
| 0.046 | 0.175 | 0.135 | Chymotrypsin inhibitor | 0.135 0.021 DBMET00328 | DBMET00328 | |
| 0.017 | 0.148 | 0.031 | Elastase 3B inhibitor | 0.031 0.02 DBMET00328 | DBMET00328 | |
| 0.017 | 0.148 | 0.031 | Elastase 2B inhibitor | 0.031 0.02 DBMET00328 | DBMET00328 | |
| 0.017 | 0.148 | 0.031 | Elastase 3A inhibitor | 0.031 0.02 DBMET00328 | DBMET00328 | |
| 0.053 | 0.194 | 0.112 | Thioredoxin inhibitor | 0.112 0.037 DBMET00585 | DBMET00585 | |
| 0.007 | 0.157 | 0.023 | O6-alkylguanine-DNA alkyltransferase inhibitor | 0.023 0.005 DBMET00585 | DBMET00585 | |
| 0.142 | 0.3 | 0.397 | Caspase 3 stimulant | 0.372 0.052 DBMET00328 0.397 0.046 DBMET00585 | DBMET00585 | |
| 0.028 | 0.192 | 0.12 | Elastase 1 inhibitor | 0.12 0.012 DBMET00328 | DBMET00328 | |
| 0.018 | 0.194 | 0.188 | Plasmin inhibitor | 0.188 0.007 DBMET00328 | DBMET00328 | |
| 0.02 | 0.196 | 0.089 | Protein kinase C eta inhibitor | 0.089 0.02 DBMET00585 | DBMET00585 | |
| 0.075 | 0.256 | 0.448 | NOS3 expression enhancer | 0.448 0.006 DBMET00585 | DBMET00585 | |
| 0.03 | 0.223 | 0.087 | Histone deacetylase stimulant | 0.087 0.038 DBMET00585 | DBMET00585 | |
| 0.03 | 0.223 | 0.087 | Histone deacetylase SIRT1 stimulant | 0.087 0.038 DBMET00585 | DBMET00585 | |
| 0.015 | 0.242 | 0.04 | Protein kinase C beta I inhibitor | 0.04 0.009 DBMET00585 | DBMET00585 | |
| 0.005 | 0.253 | 0.62 | Calpain 1 inhibitor | 0.62 0.002 DBMET00328 | DBMET00328 | |
| 0.092 | 0.376 | 0.161 | CC chemokine 6 receptor antagonist | 0.161 0.012 DBMET00585 | DBMET00585 | |
| 0.027 | 0.313 | 0.133 | DNA intercalator | 0.133 0.051 DBMET00585 | DBMET00585 | |
| 0.02 | 0.321 | 0.5 | Cathepsin B inhibitor | 0.5 0.003 DBMET00328 | DBMET00328 | |
| 0.017 | 0.362 | 0.1 | Glucose-6-phosphate translocase inhibitor | 0.1 0.006 DBMET00585 | DBMET00585 | |
| 0.002 | 0.348 | 0.073 | 3C-Like protease (MERS coronavirus) inhibitor | 0.073 0.001 DBMET00328 | DBMET00328 | |
| 0.037 | 0.391 | 0.193 | Amyloid beta aggregation inhibitor | 0.193 0.082 DBMET00585 | DBMET00585 | |
| 0.005 | 0.368 | 0.029 | Trypsin I inhibitor | 0.029 0.027 DBMET00328 | DBMET00328 | |
| 0.026 | 0.401 | 0.122 | Factor XII inhibitor | 0.122 0.023 DBMET00328 | DBMET00328 | |
| 0.013 | 0.394 | 0.107 | Lipase inhibitor | 0.107 0.024 DBMET00328 | DBMET00328 | |
| 0.031 | 0.427 | 0.358 | Anticoagulant | 0.358 0.021 DBMET00585 | DBMET00585 | |
| 0.022 | 0.424 | 0.083 | Trypsin inhibitor | 0.083 0.025 DBMET00328 | DBMET00328 | |
| 0.04 | 0.471 | 0.62 | Tumour necrosis factor alpha release inhibitor | 0.62 0.006 DBMET00585 | DBMET00585 | |
| 0.08 | 0.533 | 0.722 | Apoptosis agonist | 0.722 0.027 DBMET00585 | DBMET00585 | |
| 0.035 | 0.508 | 0.078 | Ca(v)3.1 blocker | 0.078 0.065 DBMET00328 | DBMET00328 | |
| 0.012 | 0.528 | 0.101 | Thrombin inhibitor | 0.101 0.025 DBMET00328 | DBMET00328 | |
| 0.004 | 0.538 | 0.021 | Elastase 2A inhibitor | 0.021 0.016 DBMET00328 | DBMET00328 | |
| 0.004 | 0.538 | 0.021 | Elastase 2 inhibitor | 0.021 0.016 DBMET00328 | DBMET00328 | |
| 0.004 | 0.543 | 0.021 | Motilin receptor agonist | 0.021 0.019 DBMET00585 | DBMET00585 | |
| 0.043 | 0.711 | 0.855 | Antiinflammatory | 0.855 0.009 DBMET00585 | DBMET00585 | |
| 0.019 | 0.733 | 0.235 | Antiobesity | 0.235 0.171 DBMET00585 | DBMET00585 | |
| 0.011 | 0.745 | 0.08 | Falcipain inhibitor | 0.08 0.074 DBMET00328 | DBMET00328 | |
| 0.004 | 0.753 | 0.105 | Cathepsin K inhibitor | 0.105 0.005 DBMET00328 | DBMET00328 | |
| 0.01 | 0.764 | 0.125 | Multidrug resistance-associated protein 1 inhibitor | 0.125 0.043 DBMET00585 | DBMET00585 | |
| 0.01 | 0.846 | 0.299 | Angiogenesis inhibitor | 0.299 0.093 DBMET00585 | DBMET00585 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |